CYSTADROPS DIN 02485605
Status: Marketed
Holder: RECORDATI RARE DISEASES CANADA INC
Molecule: CYSTEAMINE (CYSTEAMINE HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | CYSTEAMINE (CYSTEAMINE HYDROCHLORIDE) 0.37 % |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01XA21 MERCAPTAMINE |
| Original market date | 15-May-2019 |
| Current status date | 15-May-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Recordati Rare Diseases Canada Inc. — licence 102167, currently licensed, last inspection rating C (2022-08-17).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21855 | 2019-02-11 | New Drug Submission (NDS) |